NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
07/29/2021
Back to search
Official data from USPTO
PERFINITY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
08/04/2022
Classification
Registered
Trademark type
Combined
Nice classes
1, 9
Filing date
04/13/2011
Registration date
11/22/2011
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/29/2021
Last transaction
08/04/2022
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
2010-07-00
First use in commerce
2010-07-00
Drawing code
3
Owner type
03
Owner location
West Lafayette, IN
Examiner
BAKER,JORDAN A
Law office
L20
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of a circle array of molecules before the word "PERFINITY".
Holders and representatives
Holders
Perfinity Biosciences, Inc.
Representatives
Louis T. Perry Faegre Drinker Biddle & Reath LLP
Technical classification
Nice Classes
Class 1Class 9
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biochemical reagents for use in proteomics and genetics research; affinity reagentsfor isolatingdetecting and analyzing molecules in protein or nucleotide assays; diagnostic preparations for scientific or research use; diagnostic reagents for in vitro use in biochemistryclinical chemistry and microbiology; laboratory chemicalsan antibody reagent used for the detection of antigens for in vitro diagnostic use; reagent kits comprising antibodieslabeled standardsderivatizing agentsaptamerslectinsantibody fragmentsand/or tagged antibodies for use in biotechnology fields; reagents for research purposes
Class 9
Laboratory and industrial equipmentapparatus and chromatographic columns for the separation of proteins and polypeptidespeptidessmall moleculesantibodiesDNA or RNA species
Publications
History of USPTO decisions and trademark events.
25 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
07/29/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
07/29/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/29/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
04/15/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
11/22/2020
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/08/2017
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/08/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/08/2017
E815
TEAS SECTION 8 & 15 RECEIVED
11/29/2016
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/22/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
11/22/2011
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/06/2011
PUBO
PUBLISHED FOR OPPOSITION
09/06/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/02/2011
ALIE
ASSIGNED TO LIE
08/02/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/19/2011
XAEC
EXAMINER'S AMENDMENT ENTERED
07/19/2011
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/19/2011
GNEA
EXAMINERS AMENDMENT E-MAILED
07/19/2011
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/19/2011
DOCK
ASSIGNED TO EXAMINER
07/19/2011
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
04/19/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/18/2011
NWAP
NEW APPLICATION ENTERED
04/16/2011
Continuous trademark protection
Get notified about every new filing that threatens PERFINITY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.